1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
申请人:Impact Therapeutics, Inc.
公开号:US09102631B2
公开(公告)日:2015-08-11
Disclosed are novel 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs thereof, represented by the Formula 1:
wherein Ar, A, R1, R3-R6 are defined herein. Compounds having Formula I are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity, such as cancer.
本发明涉及一种新型1-(芳基甲基)-5,6,7,8-四氢喹唑啉-2,4-二酮及其类似物,其化学式如下:其中Ar,A,R1,R3-R6在此定义。具有式I的化合物是PARP抑制剂。因此,本发明的化合物可用于治疗对PARP活性抑制敏感的临床病症,例如癌症。